BHARAT PARENTERALS
Back to Cashflow Statement
|
BHARAT PARENTERALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹156 Cr | ₹110 Cr | ₹61 Cr | ₹9.42 Cr | ₹10 Cr |
What is the latest Cash Flow from Financing Activities ratio of BHARAT PARENTERALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹110 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.42 Cr |
| Mar2021 | ₹10 Cr |
How is Cash Flow from Financing Activities of BHARAT PARENTERALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | 41.61 | |
| Mar2024 | ₹110 Cr | 82.23 | |
| Mar2023 | ₹61 Cr | 543.15 | |
| Mar2022 | ₹9.42 Cr | -10.25 | |
| Mar2021 | ₹10 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BHARAT PARENTERALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BHARAT PARENTERALS | ₹1,010.6 Cr | -3.2% | 5.8% | -5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
BHARAT PARENTERALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BHARAT PARENTERALS | -3.2% |
5.8% |
-5.2% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses